Compugen (CGEN)
Compugen News
Compugen Earnings Call scheduled for 10:00 am ET today
about 27 days agoCompugen Ltd (CGEN) Doubles Q1 Loss to 12c/Share
Street Insider about 27 days agoQ1 2012 Compugen Earnings Release - Time Not Supplied
about 27 days agoCompugen Ltd. Reports First Quarter 2012 Financial Results
Business Wire about 27 days agoCompugen Ltd. today reported financial results for the first quarter ending March 31, 2012.
Compugen Announces Initial Validation Results for Two Novel Immunomodulatory Proteins and Further Results for CGEN-15001
Benzinga about 34 days agoDr. Mary Haak-Frendscho, Chairperson of Compugen’s US Subsidiary, to Give Keynote Address at China Pharmaceutical R&D Summit
Business Wire about 35 days agoCompugen Ltd. announced today that Dr. Mary Haak-Frendscho, Compugen Inc.'s Executive Chairperson of the Board, will deliver the keynote address at the 7th International China Pharmaceutical R&D Summit, on April 24, 2012 in Shanghai, China.
Compugen First Quarter 2012 Conference Call Scheduled for Tuesday, May 1, 2012 at 10:00 AM EST
Business Wire about 35 days agoCompugen Ltd. today announced that the Company will host a conference call at 10:00 AM EST on Tuesday, May 1, 2012 to review first quarter 2012 results. The quarterl
Compugen Establishes Operations in California for Development of Monoclonal Antibody Drug Candidates
Business Wire about 61 days agoCompugen Ltd. announced today the establishment of operations in South San Francisco, California for the development of oncology and immunology monoclonal antibody drug candidates against Compugen-discovered targets.
Hidden Stocks for High Returns
about 90 days agoCompugen Presents Prediction Based Discovery Strategy at “Targets and Strategies for Drug Discovery” Conference
Business Wire about 91 days agoSpeaking today at the Targets and Strategies in Drug Discovery Summit in Las Vegas, Dr. Gady Cojocaru, Head of Target Discovery at Compugen Ltd. , presented Compugen’s prediction based discovery strategy by focusing on two of the methodologies being utilized by the Company for the identification of novel targets for monoclonal antibody cancer therapy.
Compugen Ltd (CGEN) Posts Wider than Expected Q4 Loss
Street Insider about 111 days agoQ4 2011 Compugen Ltd Earnings Release - Time Not Supplied
about 111 days agoCompugen Ltd. Reports Fourth Quarter and Calendar 2011 Financial Results
Business Wire about 111 days agoCompugen Ltd. today reported financial results for the fourth quarter and year ended December 31, 2011.
Compugen to Present at the BIO CEO & Investor Conference 2012
Business Wire about 112 days agoCompugen Ltd. announced today that Dr. Anat Cohen-Dayag, Compugen's President and CEO, is scheduled to present at the upcoming BIO CEO & Investor Conference 2012
Compugen (CGEN) Updates on CGEN-15001T Therapeutic Potential as Cancer Treatment
Street Insider about 116 days agoYou may also be interested in these CGEN related companies
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CGEN | 3.80 | -0.25 | -6.17% | 131.90M |
| CEDU | 6.88 | +0.00 | +0.00% | 126.66M |
| CEDC | 4.04 | +0.02 | +0.50% | 295.49M |
| CECO | 7.03 | +0.72 | +11.41% | 474.81M |
| CECE | 7.15 | +0.11 | +1.56% | 103.82M |
| CEC | 35.78 | -0.22 | -0.61% | 646.90M |
| CEBK | 30.50 | +0.00 | +0.00% | 51.24M |
| CEA | 14.45 | -0.10 | -0.69% | 2.769B |
| COGO | 1.89 | +0.02 | +1.07% | |
| COG | 34.77 | -0.30 | -0.86% | 7.282B |
